Kel, Meet AI | Podcast on RSS.com

Kel, Meet AI

by Nick Warth

Business Education

Season 1

Part 12 - Pharma MR AI Gaps & Opportunities

AI in Pharma Market Research: The Next Frontier Pharma market research (PMR) is undergoing rapid transformation as AI accelerates speed, cuts costs, and deepens insight. Yet major gaps remain—creating urgent opportunities. Key Challenges in PMR: Speed vs. Depth: Fast surveys lack nuance; rich insights take too long. This trade-off is unsustainable in fast-moving therapy areas. Static vs. Continuous Insight: Clients want evolving, real-time monitoring—current offerings are mostly point-in-time. Siloed Data: Insights remain fragmented, missing cross-functional opportunities and limiting ROI. Inefficient Workflows: Manual compliance and tracking slow delivery and raise costs. Buried Insights: Findings are hidden in decks, not interactive or easily accessible. Qualitative Data Underuse: Emotions, tone, and themes often lost in manual summaries. How AI Is Already Delivering: Speed: AI cuts research time by 30–50% and regulatory submission time by 40%. Cost: R&D and trial costs drop by up to 70%. Insight: Machine learning and multimodal AI reveal patterns humans miss, combining data types for richer, real-time market intelligence. High-Potential AI Opportunities: Live Monitoring Tools (e.g., pharma-specific Brandwatch): Track sentiment, competitors, and regulation in real time. AI-Moderated Qual: Detect emotion, synthesize themes, and auto-probe responses. Conversational Portals: Let clients “chat” with data via natural language queries. Internal Synthesis Engines: Reuse past research to surface “what we already know.” Synthetic Respondents: Simulate patient insights for rare diseases or hard-to-reach groups. Autonomous Agents: Fully AI-led insight generation (longer-term). Who's Leading: Novartis, Pfizer, GSK, AZ: Investing in AI across R&D and trials. ZoomRx, Day One, Talking Medicines, GRG Health: Innovating AI-mod insight capture, synthetic data, and real-time tracking. Roadmap for PMR Firms: Now: Pilot AI qual tools and light monitoring using ChatGPT + scraping. 6–18 Months: Build conversational insight portals, reuse engines, and predictive models. 18–36 Months: Develop synthetic audiences, AI-driven reports, and market simulators. Beyond: Launch autonomous research agents and integrated discovery-insight platforms. Risks & KPIs: Risks: Data quality, compliance, adoption hurdles. KPIs: 50% faster delivery, 25% revenue uplift/client, 15pp margin gains, 80% AI-powered services. AI isn’t optional—it’s the key to PMR’s future. The firms that move first will lead.

Part 0 - What even is AI? A beginner's guide

I. Core Definition and Everyday Presence of AI What is AI? At its core, Artificial Intelligence is defined as "the way we get computers to do tasks that we normally associate with smart humans." The source emphasizes that AI does not "think" like humans but can "answer questions, suggest ideas, or even compose a neat paragraph for you." It is likened to "a really clever intern who’s trotted around the globe and absorbed a massive amount of information." AI in Everyday Life: Contrary to popular misconceptions, AI is already "woven into the tools you use every day." Common examples include: Streaming Services: Netflix or Spotify recommendations. Navigation Tools: Google Maps for fastest routes. Smart Assistants: Siri or Alexa managing tasks. Email Filters: Identifying and sending spam. Social Media Filters: Photo enhancements and feed suggestions. II. Generative AI: Creating New Content A significant aspect of modern AI is Generative AI, which "doesn’t just analyze data—it can also create something new." This type of AI takes learned patterns from "countless examples" to produce "fresh, tailor-made response." Example: Prompting it to "Describe a beautiful sunset in simple terms" results in a newly generated description. Generative AI acts "like a creative assistant who understands your style and can generate content that fits your needs." III. The 3 Key Pillars to Using AI Effectively To leverage AI, users do not need programming knowledge. The source identifies three essential concepts: Prompting: This is "simply asking the AI to do something." The effectiveness of AI largely depends on "giving clear instructions to a friend." The more precise the prompt (e.g., "'Draft a polite email to my boss,' or 'Summarize this long article in simple words'"), the better the output. Iteration: This involves refining AI's initial output. "Sometimes the first answer isn’t perfect." Users can "ask the AI to adjust the output—maybe make the tone more friendly, or simplify the language even further." It's compared to "refining a rough sketch until it suits your vision." Integration: This refers to "combining AI with the other tools you use at work, like email platforms, document editors, or note-taking apps." AI can "summarize a series of emails, generate ideas for your next report, or draft a quick reminder for your meeting," thereby working "in harmony with your daily tasks, making your work more efficient." IV. Practical Applications of AI in the Workplace AI serves as a "super-efficient assistant" in professional settings, supporting rather than replacing human effort. Key benefits include: Email and Document Drafting: Creating initial drafts for various written communications. Time-Saving Automation: Quickly scanning documents and extracting key information. Meeting Preparation: Summarizing lengthy reports. Idea Brainstorming: Acting as a "sounding board" to generate ideas and overcome creative blocks. Data Analysis: Helping to "break down charts or trends" for informed decision-making, even for those uncomfortable with data.

Part 10 AI in Pharma - The Next 2 to 3 Years

This crash course introduces artificial intelligence (AI) within the context of pharmaceutical market research, emphasizing its strategic business applications rather than technical complexities. The text explains that AI is not about robots but rather about computers excelling at pattern recognition and prediction within data. It highlights how AI is transforming the pharmaceutical industry by enabling predictive insights, reducing operational costs, and accelerating drug discovery and market trend identification. Examples from Johnson & Johnson, PepsiCo, and Unilever illustrate AI's practical benefits, demonstrating its power to augment human expertise and shift decision-making from reactive to proactive. Ultimately, the source frames AI as a tool for amplifying human intelligence and gaining competitive advantage in the pharmaceutical sector, stressing its potential to identify emerging needs and trends months ahead of traditional methods.

Part 9 Ethics, Data Privacy and Regulatory Considerations

This crash course introduces artificial intelligence (AI) within the context of pharmaceutical market research, emphasizing its strategic business applications rather than technical complexities. The text explains that AI is not about robots but rather about computers excelling at pattern recognition and prediction within data. It highlights how AI is transforming the pharmaceutical industry by enabling predictive insights, reducing operational costs, and accelerating drug discovery and market trend identification. Examples from Johnson & Johnson, PepsiCo, and Unilever illustrate AI's practical benefits, demonstrating its power to augment human expertise and shift decision-making from reactive to proactive. Ultimately, the source frames AI as a tool for amplifying human intelligence and gaining competitive advantage in the pharmaceutical sector, stressing its potential to identify emerging needs and trends months ahead of traditional methods.

Part 8 Managing AI Projects as a Non-Technical Stakeholder

This crash course introduces artificial intelligence (AI) within the context of pharmaceutical market research, emphasizing its strategic business applications rather than technical complexities. The text explains that AI is not about robots but rather about computers excelling at pattern recognition and prediction within data. It highlights how AI is transforming the pharmaceutical industry by enabling predictive insights, reducing operational costs, and accelerating drug discovery and market trend identification. Examples from Johnson & Johnson, PepsiCo, and Unilever illustrate AI's practical benefits, demonstrating its power to augment human expertise and shift decision-making from reactive to proactive. Ultimately, the source frames AI as a tool for amplifying human intelligence and gaining competitive advantage in the pharmaceutical sector, stressing its potential to identify emerging needs and trends months ahead of traditional methods.

Part 7 Common Pitfalls and Spotting Nonsense

This crash course introduces artificial intelligence (AI) within the context of pharmaceutical market research, emphasizing its strategic business applications rather than technical complexities. The text explains that AI is not about robots but rather about computers excelling at pattern recognition and prediction within data. It highlights how AI is transforming the pharmaceutical industry by enabling predictive insights, reducing operational costs, and accelerating drug discovery and market trend identification. Examples from Johnson & Johnson, PepsiCo, and Unilever illustrate AI's practical benefits, demonstrating its power to augment human expertise and shift decision-making from reactive to proactive. Ultimately, the source frames AI as a tool for amplifying human intelligence and gaining competitive advantage in the pharmaceutical sector, stressing its potential to identify emerging needs and trends months ahead of traditional methods.

Part 6 Terminology

This crash course introduces artificial intelligence (AI) within the context of pharmaceutical market research, emphasizing its strategic business applications rather than technical complexities. The text explains that AI is not about robots but rather about computers excelling at pattern recognition and prediction within data. It highlights how AI is transforming the pharmaceutical industry by enabling predictive insights, reducing operational costs, and accelerating drug discovery and market trend identification. Examples from Johnson & Johnson, PepsiCo, and Unilever illustrate AI's practical benefits, demonstrating its power to augment human expertise and shift decision-making from reactive to proactive. Ultimately, the source frames AI as a tool for amplifying human intelligence and gaining competitive advantage in the pharmaceutical sector, stressing its potential to identify emerging needs and trends months ahead of traditional methods.

Part 5 How AI is Being Applies in Pharmaceutical Market Research

This crash course introduces artificial intelligence (AI) within the context of pharmaceutical market research, emphasizing its strategic business applications rather than technical complexities. The text explains that AI is not about robots but rather about computers excelling at pattern recognition and prediction within data. It highlights how AI is transforming the pharmaceutical industry by enabling predictive insights, reducing operational costs, and accelerating drug discovery and market trend identification. Examples from Johnson & Johnson, PepsiCo, and Unilever illustrate AI's practical benefits, demonstrating its power to augment human expertise and shift decision-making from reactive to proactive. Ultimately, the source frames AI as a tool for amplifying human intelligence and gaining competitive advantage in the pharmaceutical sector, stressing its potential to identify emerging needs and trends months ahead of traditional methods.

Part 4 GenAI and Common Tools

This crash course introduces artificial intelligence (AI) within the context of pharmaceutical market research, emphasizing its strategic business applications rather than technical complexities. The text explains that AI is not about robots but rather about computers excelling at pattern recognition and prediction within data. It highlights how AI is transforming the pharmaceutical industry by enabling predictive insights, reducing operational costs, and accelerating drug discovery and market trend identification. Examples from Johnson & Johnson, PepsiCo, and Unilever illustrate AI's practical benefits, demonstrating its power to augment human expertise and shift decision-making from reactive to proactive. Ultimately, the source frames AI as a tool for amplifying human intelligence and gaining competitive advantage in the pharmaceutical sector, stressing its potential to identify emerging needs and trends months ahead of traditional methods.

Part 3 Natural Language Processing and LLMs

This crash course introduces artificial intelligence (AI) within the context of pharmaceutical market research, emphasizing its strategic business applications rather than technical complexities. The text explains that AI is not about robots but rather about computers excelling at pattern recognition and prediction within data. It highlights how AI is transforming the pharmaceutical industry by enabling predictive insights, reducing operational costs, and accelerating drug discovery and market trend identification. Examples from Johnson & Johnson, PepsiCo, and Unilever illustrate AI's practical benefits, demonstrating its power to augment human expertise and shift decision-making from reactive to proactive. Ultimately, the source frames AI as a tool for amplifying human intelligence and gaining competitive advantage in the pharmaceutical sector, stressing its potential to identify emerging needs and trends months ahead of traditional methods.

1 of 2